logo

IVF

INVO Fertility·NASDAQ
--
--(--)
--
--(--)
1.00 / 10
Underperform

The fundamental evaluation yields a score of 1.0/10, indicating challenging financial health. Key positives include a strong net profit to total profit ratio and an acceptable interest coverage ratio, but these are offset by negative asset and revenue metrics. Overall, the fundamentals are weak and caution is advised.

Fundamental(1)SentimentTechnical

Analysis Checks(4/10)

Revenue-MV
Value2.11
Score1/3
Weight6.76%
1M Return-1.83%
ROA (%)
Value-77.61
Score0/3
Weight20.34%
1M Return-7.78%
Net profit attributable to parent company shareholders / Net profit (%)
Value100.00
Score2/3
Weight6.83%
1M Return-1.71%
Net income-Revenue
Value-0.17
Score1/3
Weight9.65%
1M Return-2.55%
Cash-UP
Value-0.06
Score2/3
Weight16.66%
1M Return-4.86%
Annualized net profit margin on total assets (%)
Value-103.48
Score0/3
Weight20.34%
1M Return-7.78%
Interest coverage ratio (EBIT / Interest expense) (%)
Value15.48
Score2/3
Weight7.70%
1M Return-1.95%
Asset-MV
Value-0.50
Score3/3
Weight-17.03%
1M Return3.31%
Cash-MV
Value-0.07
Score1/3
Weight18.30%
1M Return-5.64%
Net profit / Total profit (%)
Value344.86
Score1/3
Weight10.45%
1M Return-2.89%
Is IVF fundamentally strong?
  • IVF scores 1.00/10 on fundamentals and holds a Premium valuation at present. Backed by its -194.47% ROE, -417.01% net margin, -0.09 P/E ratio, 0.45 P/B ratio, and -225.06% earnings growth, these metrics solidify its Underperform investment rating.